Moreover, the IL-10 deficient & IL-37 transgenic (IL-10KO)/IL-37tg hybrid mouse model exhibited protective effects against subsequent inflammation and colon cancer during chronic colitis, indicating that the protective effects of IL-37 in colon cancer was associated with the regulation on IL-10 (119). Here, IL37 is linked to malignant colon neoplasm.